The purpose of this notice is to recommend modified wording for the indications and clinical uses of fludeoxyglucose (F-18 FDG) products in their product monographs. The recommended wording aims to bring the indications and clinical uses for F-18 FDG up-to-date and harmonize F-18 FDG product monographs in this regard.
You can access the document here: Notice to Stakeholders: Harmonizing fludeoxyglucose (F-18 FDG) product monographs.
Back